Houston, TX, United States of America

Sunil Acharya

This inventor holds 1 USPTO granted patent and 9 published patent applications, plus 1 CIPO patent. Top assignee: The University of Texas System. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sunil Acharya. Retrieved from https://idiyas.com/inventor/sunil-acharya

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sunil Acharya: Innovator in Cancer Treatment

Introduction

Sunil Acharya is a prominent inventor based in Houston, TX (US). He has made significant contributions to the field of cancer research, particularly in the treatment of brain metastasis. His innovative approach focuses on targeting specific kinases that promote cancer spread.

Latest Patents

Acharya holds a patent titled "Targeting kinases for the treatment of cancer metastasis." This patent outlines methods for treating brain metastasis by administering a kinase inhibitor that targets a metastasis-promoting kinase identified through an in vivo kinase screen. His work is crucial in developing more effective cancer therapies.

Career Highlights

Sunil Acharya is affiliated with the University of Texas System, where he conducts his research. His dedication to advancing cancer treatment has positioned him as a key figure in the scientific community. With 1 patent to his name, he continues to push the boundaries of medical innovation.

Collaborations

Acharya collaborates with esteemed colleagues, including Dihua Yu and Frank Lowery. Their combined expertise enhances the research efforts aimed at combating cancer metastasis.

Conclusion

Sunil Acharya's work exemplifies the impact of innovative research in the fight against cancer. His contributions are paving the way for new treatment options that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…